{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-009738","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.244817+00:00","generated_at":"2026-06-19T20:06:46.810046+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sensus Healthcare Q4 net income $2.8M ($0.17 EPS); FY22 revenue up 65% to $44.5M","bullets":["Q4 2022 revenue $13.1M flat YoY; net income $2.8M ($0.17 diluted EPS) vs $5.3M ($0.32).","Full-year revenue $44.5M (+65% YoY); cash $25.5M, no debt; adjusted EBITDA $4.3M vs $5.6M.","Gross margin fell to 63.7% from 68.0% on higher manufacturing costs and inflation.","Expects continued topline growth in Q1 2023 and full-year profitability; multiple 510(k) submissions planned in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-009738","json":"https://secwatch.observer/filing/0001213900-23-009738.json","markdown":"https://secwatch.observer/filing/0001213900-23-009738.md","text":"https://secwatch.observer/filing/0001213900-23-009738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023009738/0001213900-23-009738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023009738/ea172985-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T20:06:46.810046+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e04bb5ef31253b61cb9c6e4254f84c50e31c7ae5","claim":"Sensus Healthcare, Inc. reported financial results for the three and 12 months ended December 31, 2022.","evidence_excerpt":"On February 9, 2023, Sensus Healthcare, Inc. announced via press release its financial results for the quarter and year ended December 31, 2022. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023009738/0001213900-23-009738-index.htm","confidence":0.4,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and 12 months ended December 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}